• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

  • About
    • General Information
    • Disease Research
    • Training & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti Aging Study
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Osteoarthritis
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Ways to Give
    • Tax Credit
    • Planned Giving
    • Contact Philanthropy
Home - OMRF News - Archives for OKN007

OKN007

OMRF brain tumor drug receives rare disease designations from the FDA

September 2, 2020

The drug treats fast-growing, deadly brain cancers with no effective treatment.

Filed Under: News, Technology Ventures News Tagged With: 007, administration, approval, bob, Bob Floyd, brain cancer, cancer, center, childhood, diffuse intrinsic pontine glioma, dipg, drug, FDA, Floyd, glioblastoma, glioma, Oblato, Oklahoma Medical Research Foundation, okn, OKN-007, OKN007, OMRF, OUHSC, pediatric, rare pediatric disease designation, Rheal, robert, rpdd, scientist-news, stephenson, Towner

OMRF scientists look ahead to research in 2014

January 2, 2014

A new year brings new challenges for medical researchers.

Filed Under: Featured News, News Tagged With: 2014, autoimmune disease, Axtell, Bob Axtell, cancer, Charles and Peggy Stephenson Cancer Center, Gabriel, Gabriel Pardo, James, Jonathan, jonathan wren, Judith, Judith James, lupus, multiple sclerosis, Multiple Sclerosis Center of Excellence, OKN007, Pardo, resolutions, Rheal, rheal towner, robert, scientist-news, steve prescott, Susannah Rankin, Towner, Wren

Attacking cancer on multiple fronts

May 7, 2013

Cutting off avenues for growth is key to killing tumors.

Filed Under: Diseases, Featured News, News, Research News Tagged With: brain cancer, brain tumor, glioblastoma, glioma, Huntsman Cancer Center, OKN007, OMRF, Rheal, rheal towner, robert floyd, scientist-news, Towner

Before Footer

Equal Opportunity Employer

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Ethics Point
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Ethics Point
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayTop Workplace